Evaluating the Immunogenicity of Antibody–drug Conjugates

Bioanalysis Zone recently published an article by Corinna Fiorotti, Business Development Director at BioAgilytix on the challenges associated with immunogenicity of antibody-drug conjugates (ADCs). In the article Corinna discusses risk factors of ADCs, the best approaches to testing in a variety of situations, and the future of these methods.

Click for full article
Share This